Fanconi syndrome is characterized by impaired reabsorptive function of the proximal renal tubule, resulting in excessive loss of water, glucose, amino acids, uric acid, phosphate, bicarbonate and other electrolytes \[[@r2]\]. Inherited Fanconi syndrome has been well documented in Basenji dogs \[[@r16]\], whereas acquired Fanconi syndrome is rarely recognized in dogs. Previously reported cases of acquired Fanconi syndrome occurred in dogs with hepatic copper toxicosis, leptospirosis, primary hypoparathyroidism and hereditary renal disease \[[@r1], [@r7],[@r8],[@r9],[@r10]\]. Acquired Fanconi syndrome has also been associated with exposure to ethylene glycol, streptozotocin, antibiotics and more recently, chicken jerky treats \[[@r3], [@r4], [@r11], [@r12], [@r14], [@r18], [@r20]\]. Since 2007, the Food and Drug Administration (FDA) has warned of a potential association between illness and consumption of chicken jerky treats \[[@r6]\]. Nonspecific signs have been noted, including lethargy, anorexia, vomiting, diarrhea and polyuria/polydipsia. Laboratory testing may reveal renal failure, glucosuria with normoglycemia, metabolic acidosis and generalized aminoaciduria, indicating Fanconi syndrome. Cases of Fanconi syndrome associated with chicken jerky treats have been documented in North America, Australia and Europe, but not in Asia \[[@r4], [@r11], [@r12], [@r20]\]. Notably, in almost all cases, dogs have consumed chicken jerky treats with ingredients from China. Given the global distribution of pet food products, the increase in the number of cases is worrisome worldwide. The present report describes the clinical features and treatment outcomes of a dog in Japan with Fanconi syndrome after consuming jerky treats, some of which contained ingredients from China.

A 6-year-old spayed female Jack Russell Terrier, weighing 5.4 kg, was referred to Yamaguchi University Animal Medical Center for evaluation of a 1-month history of lethargy, anorexia, vomiting and weight loss. These clinical signs were not resolved after general management at the local animal hospital. Two days before the initial visit, azotemia, hypokalemia and glucosuria were measured at the local animal hospital. The dog was fed different beef and chicken jerky treats daily, some of which contained ingredients from China, in addition to a commercial diet. Once anorexia was observed, much of her diet had been jerky treats for 1 month, as a result of her dietary preferences.

At the time of initial presentation, a blood test revealed normal complete blood cell count (CBC) and increased blood urea nitrogen (BUN) (119.8 mg/d*l*; reference range, 9.2--29.2 mg/d*l*) and creatinine (2.4 mg/d*l*; reference range, 0.4--1.4 mg/d*l*). In addition, hypokalemia (2.1 mEq/*l*; reference range, 3.8--5.0 mEq/*l*) and hyperchloremia (122 mEq/*l*; reference range, 102--117 mEq/*l*) were also revealed. Blood glucose was within the normal range (95 mg/d*l*; reference range, 75--128 mg/d*l*). Urinalysis showed a specific gravity of 1.038, a pH of 6.0, moderate glucosuria (250 mg/d*l*, determined by dipstick) and trace proteinuria (30 mg/d*l*, determined by dipstick). Urine protein/creatinine ratio was 0.42 (reference range, \<0.5). Urine sediment identified epithelial and granular casts without hematuria, pyuria or bacteriuria. Venous blood gas analysis showed metabolic acidosis with a pH of 7.292 (reference range, 7.35--7.45), a venous CO~2~ pressure (PvCO~2~) of 32.7 mm Hg (reference range, 40--50 mm Hg), a bicarbonate concentration of 15.4 mmol/*l* (reference range, 20--24 mmol/*l*) and a base excess (BE) of −9.9 mmol/*l*(reference range, −4 to +4 mmol/*l*). No significant abnormalities were observed on radiography and abdominal ultrasonography.

Because of the suspicion of Fanconi syndrome, a spot urine sample was submitted for amino acids and derivatives analysis by high performance liquid chromatography (Bio Medical Laboratories, Saitama, Japan). To correct for the influence of urinary concentration or dilution in spot urine samples, the urinary excretions of amino acids and derivatives were adjusted for the urinary creatinine concentration (*µ*mol/g of creatinine) as described previously \[[@r22]\]. Because reference values for the urine amino acids and derivatives profile had not been established, the measured value was compared with that of three healthy dogs. Increased excretion of most amino acids was found, but not all amino acids and derivatives were lost equally ([Table 1](#tbl_001){ref-type="table"}Table 1.Urine amino acids and derivatives profile (mmol/g·cre)\*SubstanceInitial visitThree months afterReference value\*\*Taurine173.41,988.97,049.4 ± 3,439.1Phosphorthanol-amine70.1201.260.9 ± 48.7Aspartic acid3.414.15.9 ± 3.4Hydroxyproline211.2153.4NDThreonine4,587.4659.279.9 ± 88.1Serine1,531.5267.7126.6 ± 30.5Asparagine851.998.329.9 ± 25.8Glutamic acid122.944.225.9 ± 12.9Glutamine11,874.9635.798.7 ± 47.3Sarcosine28.2306.0NDα-Aminoadipic acid166.396.632.0 ± 19.2Proline173.4203.9NDGlycine3,544.5396.468.7 ± 31.3Alanine6,077.1583.9192.3 ± 103.7Citrulline1,956.7503.527.1 ± 12.9α-Amino-n-butyric acid250.29.12.3 ± 1.1Valine373.990.121.3 ± 5.1Cystine633.6114.427.6 ± 9.7Methionine57.9244.645.3 ± 56.9Cystathionine251.9356.811.2 ± 10.0Isoleucine123.42.45.5 ± 2.3Leucine185.412.739.4 ± 18.2Tyrosine552.112.5NDPhenylalanine247.45.34.3 ± 1.3β-Alanine25.460.872.6 ± 44.4β-Amino-iso-butyric acid45.3136.831.8 ± 16.7Homocystine40.6NDNDγ-Amino-n-butyric acidNDNDNDEthanolamine149.1150.791.8 ± 10.7Hydroxylysin6.7NDNDOrnithine108.126.012.1 ± 7.1Tryptophan316.111.55.9 ± 5.1Lysine423.851.544.0 ± 18.71-Methyl-histidine516.7522.3688.1 ± 493.1Histidine1,567.3118.819.1 ± 2.83-Methyl-histidine384.8265.8177.1 ± 40.5AnserineNDNDNDCarnosine10.1NDNDArginine97.754.217.4 ± 6.9\*The concentrations of amino acids and derivatives (mmol/*l*) were calibrated by the concentration of creatinine (g/*l*). \*\*The reference values were calculated as average ± 2 standard deviation of the concentrations of amino acids and derivatives in 3 healthy dogs. ND: Not detected). Given glucosuria in the absence of hyperglycemia, metabolic acidosis and generalized aminoaciduria, a diagnosis of Fanconi syndrome was established.

The possible cause of Fanconi syndrome was carefully explored. Medications associated with acquired Fanconi syndrome, such as antibiotics, nonsteroidal anti-inflammatory drugs and cyclosporine, had not been administered prior to onset of clinical signs. It was highly unlikely that the dog was exposed to environmental toxins, such as cadmium, lead and mercury, according to the dog's history and life circumstances. Hepatic copper toxicosis and primary hypoparathyroidism were excluded by the absence of hepatic insufficiency and hypocalcemia, respectively. Titers for *Leptospira interrogans*(serovars canicola, icterohaemorrhagiae and hebdomadis) were examined and eventually reported as negative. In humans, Fanconi syndrome may result from tubular injury related to urinary excretion of abnormal proteins, such as multiple myeloma and amyloidosis \[[@r13], [@r17]\]. In the dog, multiple myeloma was excluded by the absence of hyperproteinemia and osteolytic bone lesions. Amyloidosis was also excluded by the absence of proteinuria, although a renal biopsy was not performed. Urinary tract infection and pyelonephritis could not be definitively excluded, because a urine culture was not performed; however, they were highly unlikely as the cause of Fanconi syndrome in the dog, because pyuria and bacteriuria were not observed in the urine sediment. On the basis of the case history and findings, the excess consumption of jerky treats was strongly suspected as the cause of Fanconi syndrome.

The dog was hospitalized and treated with acetated Ringer's solution with 40 mEq/*l* of potassium chloride. The dog was also treated with potassium sodium hydrogen citrate (Uralyte^®^, 231.5 mg of potassium citrate and 195 mg of sodium hydrogen citrate, PO, BID), famotidine (0.5 mg/kg, IV, SID) and metronidazole (11 mg/kg, PO, BID). The jerky treats were immediately withdrawn. On day 2 of hospitalization, BUN (78.5 mg/d*l*), creatinine (2.1 mg/d*l*), potassium (3.0 mEq/*l*) and chloride (122 mEq/*l*) levels were measured. Metabolic acidosis was resolved (pH, 7.402; PvCO~2~, 36.9 mm Hg; bicarbonate, 22.5 mmol/*l*; and BE, −1.9). Glucosuria was still present, but it mildly improved (100 mg/d*l*, determined by dipstick). On day 3 of hospitalization, BUN (49.2 mg/d*l*), creatinine (1.9 mg/d*l*), potassium (2.9 mEq/*l*) and chloride (119 mEq/*l*) levels were measured again. Metabolic acidosis continued to improve (pH, 7.393; PvCO~2~, 36.9 mm Hg; bicarbonate, 22.0 mmol/*l*; and BE, −2.5). Glucosuria was still present (100 mg/d*l*, determined by dipstick). On day 4 of hospitalization, the dog was discharged, although her appetite had not improved. After discharge, the dog was treated with the same regimen everyday at the local animal hospital. Three days after discharge, partial improvement in her appetite was observed, and glucosuria was completely resolved. Because mild azotemia remained, daily subcutaneous fluid therapy was continued. Three months after the initial administration, no clinical signs were observed. The CBC was normal. However, mild azotemia remained (BUN, 36.2 mg/d*l* and creatinine, 2.0 mg/d*l*), resulting in chronic kidney disease. The urinalysis showed complete resolution of glucosuria. The urine amino acid analysis revealed that aminoaciduria was substantially, but not completely, improved ([Table 1](#tbl_001){ref-type="table"}).

Renal tubular acidosis (RTA) has been classified into distal RTA and proximal RTA based on the anatomic location of tubular defect. Proximal RTA caused by impaired bicarbonate reabsorption in the proximal renal tubule is a characteristic of Fanconi syndrome. Proximal RTA typically causes hyperchloremic metabolic acidosis secondary to loss of bicarbonate, hypokalemia due to promoted potassium excretion and acidic urine due to secretion of hydrogen ions in the distal tubule. In the dog, the presence of hyperchloremic metabolic acidosis, hypokalemia and acidic urine supported a diagnosis of proximal RTA. In conjunction with proximal RTA, glucosuria without hyperglycemia and generalized aminoaciduria indicated a generalized proximal renal tubular defect and confirmed the diagnosis of Fanconi syndrome.

In the dog, the urinary loss of most amino acids was increased, but not all amino acids, and derivatives were lost equally. Dogs with Fanconi syndrome typically have generalized aminoaciduria including acidic, basic and neutral amino acids. In a previous report, a dog with idiopathic Fanconi syndrome appeared to have increased excretion of amino acids with basic side chains, whereas those with acidic side chains (i.e., aspartic acid and glutamic acid) were less affected \[[@r18]\]. Interestingly, the dog in this report had no urinary loss of aspartic acid, and excretion of glutamic acid was elevated but not excessive. The differences may be related to defects in specific amino acid transport mechanisms depending on the underlying causes. In addition, the urinary concentration of taurine was reduced in the dog compared with that in normal dogs. A previous report indicated that urinary excretion level of taurine could be affected by the quantity of taurine and other components contained in ingested food \[[@r21]\]. The differences of urinary taurine concentration between the affected dog and control dogs may be related to the consumed diets.

The dog was fed different beef and chicken jerky treats daily, some of which contained ingredients from China. After symptom onset, much of her diet had been jerky treats for 1 month. After diagnosis of Fanconi syndrome, on the basis of the case history and extensive diagnosis testing, jerky treats were strongly suspected as the cause of Fanconi syndrome. Indeed, 1 week after their withdrawal, glucosuria was completely resolved, and the dog's appetite was gradually improved. After 3 months, there were no clinical signs, and aminoaciduria was substantially improved. According to the clinical course, jerky treats were eventually concluded to be the cause of Fanconi syndrome in the dog. Unfortunately, the specific product could not be identified as the causal component, because the dog had been fed several kinds of jerky treats. However, all jerky treats consumed by the dog could be commonly purchased in Japan. In fact, it should be noted that toxicosis associated with jerky treats can unsurprisingly occur in Japan.

The common clinical features of Fanconi syndrome associated with chicken jerky treats have been documented in previous reports \[[@r11], [@r20]\]. The clinical signs observed in this case, including lethargy, anorexia, vomiting and weight loss, were similar to those observed in previous cases. Small breeds (\<10 kg) appear to be mostly affected, accounting for 88%. The dog in this report also weighed \<10 kg (5.4 kg). This is likely because of the proportionally larger quantity of jerky treats consumed in small breeds. The period of time that jerky treats were fed prior to the onset of clinical signs ranged from 0.3 to 78 weeks in previous cases. Although the precise period of time that jerky treats were fed in this case was unknown, severe azotemia was documented 1 month after the onset of lethargy and anorexia. In this period, renal function appeared to be severely damaged, because of the increase in the quantity of jerky treats consumed. The dog continued to have mild azotemia 3 months after treatment, suggesting irreversible renal dysfunction. Indeed, despite the withdrawal of jerky treats, permanent kidney damage appears to occur in some cases, resulting in chronic renal disease \[[@r20]\]. A histopathological examination of the kidney in acute and chronic phases may be helpful to reveal the mechanism underlying renal damage.

At the time of writing, despite extensive investigations by the FDA, the specific causative substance has not been determined, and unfortunately, it could not be investigated in this report. In humans, degraded tetracyclines have been implicated as a cause of acquired Fanconi syndrome \[[@r5], [@r15]\]. Recently, 6 illegal antibiotics, including trimethoprim, tilmicosin, enrofloxacin, sulfaclozine and sulfamethoxazole, have been detected in chicken jerky products for dogs \[[@r19]\]. However, there is no evidence indicating the relation between these antibiotics and the illness. Further investigations of the causative substance, including contaminating antibiotics and others, are warranted.

In conclusion, this is the first reported case of Fanconi syndrome following the consumption of jerky treats in Japan. For diagnosis of this disease, it is important to take a careful dietary history and perform urinalysis in dogs with nonspecific signs. If an association between the illness and jerky treat consumption is suspected, such treats should be immediately withdrawn, although irreversible renal dysfunction may remain. Veterinary clinicians should be aware of the toxicosis associated with jerky treats and report cases to regulatory authorities to prevent outbreaks.
